Award notice Supplies

Meropenem injectable

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: MercurHosp ASBL
Erpent
Place of performance: 5101 Erpent, Namur
not published: buyer's address
Amount awarded: €440,575 excl. VAT
Planned end of contract: 2 June 2029
likely re-tender around December 2028
Bids received: 2
Procedure: Open procedure
Any company may submit a bid.
Publication: 30 September 2025
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Marché de fourniture de meropenem injectable 1000 mg

Awarded to

Fresenius Kabi

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Fourniture d'azaticidine MercurHosp ASBL · 3 August 2026	Fresenius Kabi	€67,433
Générateurs de Technétium (99M Tc) et produits radiopharmaceutiques MercurHosp ASBL · 1 October 2025	GE HEALTHCARE CISBIO International Curium Belgium	€12,256,476
Fourniture d'analogues de la somatostatine MercurHosp ASBL · 1 October 2025	Pharmanovia Benelux B.V. NOVARTIS PHARMA	€606,086
Fourniture de Gemcitabine MercurHosp ASBL · 30 September 2025	ACCORD HEALTHCARE	€256,160
ATOSIBAN IV MercurHosp ASBL · 30 September 2025	FERRING	€391,336

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 637040-2025.